JAYLA SCALF: Open Payments
NPI 1184382780 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,631 in 171 payments from 31 companies in 2025. Trend: 2023 $1,926 · 2024 $3,029 · 2025 $2,631
Food & beverage: $2,547Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $546 |
| UCB, Inc. | 14 | $260 |
| PFIZER INC. | 19 | $169 |
| Lundbeck LLC | 9 | $160 |
| ARGENX US, INC. | 10 | $160 |
| Janssen Biotech, Inc. | 6 | $160 |
| Novartis Pharmaceuticals Corporation | 8 | $148 |
| Alexion Pharmaceuticals, Inc. | 6 | $135 |
| Octapharma USA, Inc. | 4 | $98 |
| EMD Serono, Inc. | 4 | $78 |
Products named: QULIPTA, Rystiggo, NURTEC ODT, VYEPTI, VYVGART, KESIMPTA, UBRELVY, ULTOMIRIS.
Industry payments across KY — which companies pay providers there.
